Ingevity (NYSE:NGVT) Posts Earnings Results, Beats Estimates By $0.66 EPS

Ingevity (NYSE:NGVT) issued its earnings results on Tuesday. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.66, Zacks reports. Ingevity had a negative net margin of 38.11% and a positive return on equity of 24.46%. Ingevity updated its FY 2025 guidance to EPS.

Ingevity Stock Up 1.4 %

Ingevity stock traded up $0.62 during midday trading on Tuesday, hitting $45.72. 297,202 shares of the stock were exchanged, compared to its average volume of 203,103. Ingevity has a 1 year low of $30.90 and a 1 year high of $56.29. The firm has a market cap of $1.66 billion, a P/E ratio of -2.94 and a beta of 1.64. The company has a debt-to-equity ratio of 6.52, a current ratio of 1.76 and a quick ratio of 1.04. The company has a 50 day moving average price of $43.31 and a two-hundred day moving average price of $40.89.

Analysts Set New Price Targets

Separately, BMO Capital Markets raised their target price on shares of Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Ingevity presently has a consensus rating of “Moderate Buy” and an average price target of $52.17.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.